专利号:US-8143035-B2 优先权日:2006-09-22 标题 :Pantothenate kinase overexpression and pantothenic acid supplementation in actinomycetes 发明人:LEE HEI CHAN; SOHNG JAE KYUNG; SAN KA-YIU 权利人:LEE HEI CHAN; SOHNG JAE KYUNG; SAN KA-YIU; RICE UNIVERSITY 摘要:The invention relates to the synthesis of polyketides in Actinomycetes by overexpression of pantothenate kinase and supplementation with pantothenic acid. This results in increasing in vivo CoA production and thereby drives increased production of secondary metabolites, such as polyketides.
专利号:US-9295731-B2 优先权日:2013-04-01 标题 :Cleavable drug conjugates, compositions thereof and methods of use 发明人:NGUYEN MARK QUANG 权利人:NGUYEN MARK QUANG 摘要:Base-labile crosslinkers, base-labile conjugates comprising such crosslinkers, methods of their synthesis and use are disclosed.
专利号:US-7199128-B2 优先权日:2005-02-02 标题 :8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents 发明人:BRADBURY BARTON J; WILES JASON ALLAN; DESHPANDE MILIND; WANG QIUPING; HASHIMOTO AKIHIRO; LUCIEN EDLAINE 权利人:ACHILLION PHARMACEUTICALS INC 摘要:The invention provides compounds and salts of Formula I and Formula II: n nwhich possess antimicrobial activity. The invention also provides novel synthetic intermediates useful in making compounds of Formula I and Formula II. The variables A 1 , A 8 , R 2 , R 3 , R 5 , R 6 , R 7 , and R 9 are defined herein.n n Certain compounds of Formula I and Formula II disclosed herein are potent and selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula I or Formula II and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula I or Formula II as the only active agent or may contain a combination of compounds of Formula I and/or Formula II and one or more other active agents. The invention also provides methods for treating microbial and protozoal infections in animals.
专利号:US-2014315720-A1 优先权日:2012-10-24 标 题 :Polysaccharide ester microspheres and methods and articles relating thereto 发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY 权利人:CELANESE ACETATE LLC 摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.
1: Bowen DK, Dielubanza E, Schaeffer AJ. Chronic bacterial prostatitis and chronic pelvic pain syndrome. BMJ Clin Evid. 2015 Aug 27;2015. pii: 1802. Review. 2: Cohen JM, Fagin AP, Hariton E, Niska JR, Pierce MW, Kuriyama A, Whelan JS, Jackson JL, Dimitrakoff JD. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis. PLoS One. 2012;7(8):e41941. doi: 10.1371/journal.pone.0041941. Epub 2012 Aug 1. Review. 3: Le B, Schaeffer AJ. Chronic prostatitis. BMJ Clin Evid. 2011 Jul 4;2011. pii: 1802. Review.
合成参考文献
摘要:Martini E, Vaggi L, Rucci A, Di Clemente L. [Non surgical treatment of benign prostatic hypertrophy]. J Urol (Paris). 1993;99(6):278–82. 摘要:Micali F, Giurioli A, Virgili G, Vespasiani G. [Mepartricin as medical treatment of benign prostatic hypertrophy]. J Urol (Paris). 1993;99(6):293–5.